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Jagjeeth B. Naik, MD, FRCS,c S. Rao Vallabhaneni, MD, FRCS,c John A. Brennan, MD, FRCS,c and
Richard G. McWilliams, FRCR, EBIR,d Liverpool, United Kingdom
Objective: This article reports the incidence, timing, and related sequelae for proximal and distal migration of the Zenith
Fenestrated AAA Endovascular Graft (Cook Medical, Bloomington, Ind) used to treat abdominal aortic aneurysms.
Method: A prospectively maintained database at a tertiary referral hospital was used to identify 83 patients who underwent
endovascular repair using the Zenith fenestrated stent graft. Inclusion criteria included a postoperative computed
tomography (CT) scan within 6 weeks of implantation and at least one additional follow-up CT scan (>5months) available
electronically at our institution. Eligible patients underwent assessment of stent graft migration using a CT-based central
luminal line (CLL) technique. The proximal and distal margins of the stent graft were measured using CLLs relative to
vascular landmarks on all available follow-up CT scans. Migration was deﬁned as stent graft movement $4 mm.
Results: Fifty-ﬁve patients were included in this study, mean age was 74 6 7 years, and 89% were men. Mean preoperative
aneurysm diameter was 67 6 9 mm. In these 55 patients, fenestrations were applied to 162 target vessels with the
commonest design accommodating two renal arteries (RAs) and the superior mesenteric artery (SMA). Median follow-up
was 24 (range, 5-97) months; 80% of patients (n[ 44) had both the proximal and two distal attachment sites assessed for
evidence of migration. Twelve iliac limbs in 11 patients were excluded from analysis due to occlusion of one internal iliac
artery precluding CLL assessment (n[ 7), or image quality issues (n[ 5). Using CLLs and based on those patients who
exhibited migration, the median proximal and distal migration distances wereD5.0 (range,D4.0 toD8.1) mm andL5.0
(range,L4.3 toL21.3) mm, respectively. Kaplan-Meier analysis for proximal migration revealed migration rates of 14%
and 22% at 12 and 36 months, respectively. Distal migration rates were lower at 3% and 8%, respectively. There have been
no incidences of late rupture or open conversion. Of the patients with proximal migration, two patients lost a single target
vessel (two RAs) and three patients were reported to have target vessel stenosis (two SMAs, one RA). These cases did not
require reintervention.
Conclusions: Both suprarenal fabric extension and visceral artery stenting are known to provide additional ﬁxation for
fenestrated aortic stent grafts. Despite this, minor proximal migration still occurs in up to one quarter of fenestrated
endovascular repair patients by 4 years. We believe this is mainly due to the engagement of the barbs of the anchoring
stent. Distal migrations occur with lower frequency. (J Vasc Surg 2013;57:1543-52.)Twenty-ﬁve to seventy-ﬁve percent of all abdominal
aortic aneurysms (AAAs) are anatomically unsuitable for
standard infrarenal endovascular repair.1,2 Complex endo-
vascular techniques, such as fenestrated endovascular repair
(FEVAR), have been developed for these situations.
Fenestrated stent grafts are subject to the same hemo-
dynamic forces that have resulted in migration of standard
infrarenal stent grafts.3 Movement at the proximal seal
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ostia. This may result in compromise of blood ﬂow to
the target vessels and/or loss of an aortic seal.
Early identiﬁcation of any migration is critical. Recog-
nition can alert the clinician to the presence of device insta-
bility and may allow early reintervention which may avert
serious clinical sequelae.4 Migration of a fenestrated stent
graft has been previously reported.5-10 In these short-
and midterm reports, device migration is generally poorly
deﬁned and rates are based on cases resulting in clinical
signs or requiring reintervention.
Migration of an infrarenal stent graft is often classiﬁed
using the Society for Vascular Surgery/International
Society for Cardiovascular Surgery reporting standards as
any movement $1.0 cm or that caused symptoms or
required reintervention.11 This deﬁnition is likely to be
insufﬁcient for fenestrated stent grafts where smaller move-
ments have been associated with sequelae.8 Modern multi-
detector computed tomography (MDCT) scanning, when
combined with a validated measurement technique,12 has
been shown to allow the quantiﬁcation of more subtle
levels of migration.
Cephalad forces acting on the iliac limbs13 can also
inducemigration. Iliac limbmigration, although infrequent,
can occur at any time point.14 As with proximal fenestrated
stent graft migration, the incidence and consequences of1543
Fig 1. A proximal measurement (db) has been undertaken using
the baseline central luminal line (CLL) computed tomography
(CT) image. The ﬁrst oblique axial reformatted image, where at
least two stents struts were visible (circles), was considered indic-
ative of the proximal stent position. The ﬁrst reformatted slice
where there was a clear space between the superior mesenteric
artery (SMA) and the aortic wall was considered the inferior border
of the reference vessel (arrow). Lines perpendicular to the CLL
demonstrate the projection of each oblique reformat and indicate
the central point within each reconstructed slice.
Fig 2. A central luminal line (CLL) computed tomography (CT)
measurement (db) taken at the distal landing zone on the baseline
CT scan. The position of the distal stent graft is recorded relative
to the bifurcation of the common iliac artery (CIA). The ﬁrst
oblique axial reformatted image where at least two stents struts
were visible was considered indicative of the distal stent position
(circles). The ﬁrst reformatted slice where there was a clear space
between the external iliac artery (EIA) and the internal iliac artery
(IIA) was considered the level of the iliac bifurcation (arrow).
Lines perpendicular to the CLL demonstrate the projection of
each oblique reformat and indicate the central point within each
reconstructed slice.
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seeks to quantify the incidence, timing, and effects of both
proximal and distal migration in patients with fenestrated
stent grafts.
METHODS
Study design and patient sample. This is a retrospec-
tive review of prospectively collected data for all patients
treated for short necked and juxtarenal AAAs with
a custom-designed fenestrated device based on the
Zenith system (Cook Inc, Bloomington, Ind). Research
ethics approval was obtained, and patients were considered
for inclusion if they had a fenestrated device implanted
between the start of our fenestrated program in 2003 and
2010. Patients were required to have had a baseline (ﬁrst)
postoperative CT scan and at least one additional CT scan
(minimum of 5 months from the baseline) available in
Digital Imaging and Communications in Medicine
(National Electrical Manufacturers Association, Rosslyn,
Va) imaging format.
Image acquisition and reconstruction. Follow-up
imaging studies were typically undertaken within 1 month,
then at 6 and 12 months, and then annually thereafter.
MDCT studies of the abdomen and pelvis were acquired
using a Siemens Somatom Sensation 16 (Siemens, Erlan-
gen, Germany). Collimation was set to 2.0 mm with
a 1.0 mm reconstruction interval. Acquisitions followed
intravenous injection of 100 mL ioversol (Optiray 300;
Mallinckrodt, Hazelwood, Mo) at 5 mL/s and were initi-
ated using bolus tracking software. Aortic enhancement at
the level of the 12th thoracic vertebra must have exceeded
120 HU. Data were reconstructed using a B20f kernel and
transferred to a workstation (Kodak Carestream PACS,
10.2; Kodak, Rochester, NY) for analysis.
Migration deﬁnition. Our deﬁnition of stent graft
migration was derived from previously published work.12
These experiments included an assessment of intra- and
interobserver variability for the measurement technique. In
summary, migration was deﬁned as cranial or caudal
movement of the device, relative to a vascular landmark of
$4 mm. Migration assessments included an evaluation of
both the proximal and both distal landing zones.
Component separation was deﬁned as any movement
between the proximal fenestrated component and the distal
bifurcated part.
Migration analysis. A central luminal line (CLL) was
created using the semiautomated CLL algorithm on the
workstation. The location of the CLL within the central
channel of the vessel lumen was conﬁrmed by scrolling
through multiplanar reformatted images. Reconstructions
perpendicular to the CLL were also evaluated to conﬁrm
exact locations when undertaking measurements (Figs 1
and 2). The proximal native vascular reference point was
the superior mesenteric artery (SMA). The distance
between the inferior border of the SMA and the ﬁrst
appearance of the stent graft (two struts) was measured.
The inferior border of the SMA was deﬁned as the ﬁrstoblique axial CLL reformatted image where there is clear
separation of the SMA from the aortic wall (Fig 1). The
iliac bifurcation was used as the distal reference point and
was deﬁned as the ﬁrst oblique axial CLL reformatted
Fig 3. A central luminal line (CLL) image from the 2004 ﬁrst postoperative follow-up computed tomography (CT) scan
(a), the proximal portion of the fenestrated stent graft was sitting 24.5 mm above the inferior border of the superior
mesenteric artery (SMA). On the 2004 three-dimensional (3D) volume-rendered (VR) image (b) the top of the bare stent
struts were in line with the origin of the celiac axis (arrow). By 2011, the stent graft had moved caudally 8.0 mm, the
proximal margins of the device are now resting 16.5 mm above the inferior border of the SMA (c). On the 2011 3D VR
image (d) there is clear evidence of caudal migration with an absence of stent graft covering the infraceliac aorta (arrow).
Fig 4. A central luminal line (CLL) (a) and three-dimensional (3D) volume-rendered (VR) images (b) from the 2005
ﬁrst postoperative follow-up computed tomography (CT) scan, the distal portion of the left iliac limb was sitting 37.3
mm above the bifurcation of the right common iliac artery (CIA). By 2011 the limb had moved cranially 7.8 mm, the
distal margins of the device are now resting 45.1 mm above the CIA bifurcation (c). On the VR images (d) cranial
movement of the device between the two time points can clearly be seen in relation to vascular calciﬁcation (*).
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 6 England et al 1545
Fig 5. Study inclusions and losses. CT, Computed tomography;
FEVAR, fenestrated endovascular repair.
Table I. Study group demographics and risk factors
Patient characteristics
Inclusions
(n ¼ 55), No. (%)
Exclusions
(n ¼ 28), No. (%)
Mean age 6 SD, years 74 6 7 71 6 8
Hypertension 30 (55) 14 (50)
Diabetes 5 (9) 4 (14)
Coronary artery diseasea 32 (58) 15 (54)
Cerebrovascular diseaseb 8 (15) 6 (21)
Renal insufﬁciencyc 8 (15) 4 (14)
ASA grade
II 14 (25) 8 (29)
III 39 (71) 19 (68)
IV 2 (4) 1 (4)
ASA, American Society of Anesthesiologists; SD, standard deviation.
aPrevious myocardial infarction, angina, or electrocardiogram evidence
of ischemia.
bPrevious stroke or transient ischemic attack.
cPreoperative serum creatinine >150 mmol/L.
Table II. Conﬁguration of scallops and fenestrations
used within the study group
Unstented Stented
Scallop Fenestration Scallop Fenestration
CA 11
SMA 33 1 13
Renal 3 4 97
CA, Celiac axis; SMA, superior mesenteric artery.
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external iliac arteries (Fig 2). Length measurements were
obtained using the CLL to measure from the proximal
stent graft to the SMA and from the distal extremes of the
stent graft to the iliac bifurcation (bilaterally) using the ﬁrst
postoperative CT scan. Each CLL measurement was then
compared with the same measurement on all available
subsequent CT scans. Measurement differences between
the baseline and subsequent CT scans, for the same
anatomical location, would be suggestive of device migra-
tion. Caudal migration of the stent graft was indicated by
a plus sign and cranial movement was indicated using
a minus sign. Measurements were recorded to 1/10 mm.
Using the CLL data, any patient meeting our deﬁni-
tion of device migration was subjected to further scrutiny.
This included visual analysis of the reconstructed aortic
segment from which speciﬁc landmarks were identiﬁed
within the aortic wall (eg, calciﬁcation). These images, in
addition to the CLL data, were assessed by two observers
to conﬁrm whether the device had migrated with respect
to its initial implanted position. Examples are provided in
Figs 3 and 4.
Statistical analysis. SPSS Statistics 20.0 (IBM,
Armonk, New York) was used for the statistical analysis.
Variables are expressed as mean 6 standard deviation in
cases of distributions that are approximately normal. The
median plus the range were reported if the data were not
approximately normally distributed. Migration distances
were only reported for patients who met our migration
deﬁnition. Kaplan-Meier methods using interval
censoring were used to construct survival curves for prox-
imal, distal, and any device migration. To facilitate this
survival, data were computed with the R v2.14.1 statistical
programming language (R Foundation for Statistical
Computing, Vienna, Austria). Estimations of migration-
free survival were generated using nonparametric
maximum likelihood estimations to deal with interval
censored data.15,16 Differences between iliac limb types
(ipsilateral/contralateral) were assessed by visual inspection
of the curves. The effect of migration on target vesselpatency (stenosis, occlusion), endoleak (type I), aneurysm
rupture, and the need for reinterventions was assessed.
RESULTS
A total of 83 patients with juxtarenal AAAs were
treated with fenestrated stent grafts during the study
period. Eight patients were followed up in other hospitals
and have therefore been excluded. Other losses are
summarized in Fig 5. There were a total of 55 patients
included, 49 men and six women with a mean age of
74 6 7 years. Preoperative comorbidities and risk factors
are listed in Table I. Eighteen (33%) patients died during
follow-up; review of our vascular database indicated that
none was aneurysm-related. Mean maximal AAA diameter
was 67 6 9 mm. The total number of fenestrations was
162; the most common combination included two small
renal artery (RA) fenestrations and an SMA scallop
(Table II).
Of 55 patients with a median follow-up of 24 months
(range, 5-97 months), 10 (18.2%) showed evidence of
proximal migration (median distance, þ5.0 mm; range,
þ4.0 to þ8.1 mm). Graft-related events and reinterven-
tions are displayed in Table III. Based on a follow-up of
130.2 person-years, this produced a proximal migration
rate of one migration per 12.5 person-years of follow-up.
Kaplan-Meier survival analysis estimated that the probabil-
ities of being free from proximal migration at 12 and 36
Table III. Outcomes of patients with CT evidence of proximal stent graft migration
Patient/
device
Time to
migration,
months
Migration
distance,
mm
Pre-op
AAA
diameter,
mm
Latest
AAA
diameter,
mm
Change
in AAA
diameter,
mm Endoleak TV event
Component
separation Outcome
1 (1S 2F) 36.9 þ8.0 59 40 19 No LRA stenosis
(Bridge
Assurant,
uncovered)
No LRA stenosis on ﬁrst post-
operative CT. Alive at
LFU (8 years), renal
function stable, no
reinterventions.
2 (1S 2F) 36.8 þ7.4 70 39 31 Type II No No Clinical sequelae/reinter-
vention free at LFU (5
years). Died e NARC.
3 (1S 3F) 24.3 þ6.2 80 46 34 No No No Clinical sequelae/ reinter-
vention free at LFU (6
years). Died e NARC.
4 (1S 2F) 84.7 þ6.2 69 87 þ18 Type II No Yes Modular distraction of the
main body. Bridging
stent graft was im-
planted at 36 months.
No further complica-
tions/ reintervention.
Patient alive at LFU
(9 years).
5 (1S 2F) 24.2 þ5.3 63 35 28 Type II SMA stenosis
(unstented
scallop)
No Clinical sequelae/reinter-
vention free at LFU (8
years). Died e NARC.
6 (1S 2F) 30.5 þ5.0 58 59 þ1 No LRA occlusion
(Jostent,
covered)
No LRA lost on 2-year CT.
Migration reported 6
months later. Serum
creatinine rose from 93
to134 mmol/L during
follow-up. No reinter-
vention. Patient with-
drew from follow-up
after 5 years, died e
NARC.
7 (1S 2F) 11.3 þ4.7 59 57 2 No LRA occlusion
(Advanta V12,
covered)
No Minor renal artery stenosis
and calciﬁcation on
preoperative CT. LRA
occlusion because of
continuation of renovas-
cular disease. Stable
renal function, patient
alive at LFU (2 years),
no reintervention.
8 (1S 2F) 62.8 þ4.1 78 70 8 No No Yes Modular distraction of the
main body overlap at 4
years. Distraction led to
kinking of the contra-
lateral limb and was
treated with a Wallstent.
Patient alive and com-
plication/further rein-
tervention free at LFU
(7 years).
9 (1S 2F) 11.7 þ4.1 64 46 18 No SMA stenosis
(Advanta V12,
covered)
No Alive/free from clinical se-
quelae/reintervention at
LFU (2 years).
10 (1S 1F) 13.0 þ4.0 71 77 þ6 Type II No No Alive/ free from clinical
sequelae/reintervention
at LFU (2 years).
AAA, Abdominal aortic aneurysm; CT, computed tomography; F, stented fenestration; LFU, last follow-up; LRA, left renal artery; NARC, nonaneurysm-
related cause; S, unstented scallop; SMA, superior mesenteric artery; TV, target vessel.
Changes in AAA diameter: negative values denote a reduction in AAA diameter whereas positive values highlight an increase. Target vessel stent data: Jostent;
Jomed International, Helsingborg, Sweden; Advanta V12; Atrium, Hudson, NH; Bridge Assurant; Medtronic, Santa Rosa, Calif.
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Fig 6. Frequencies of proximal and distal stent graft migration. In
the two cases of iliac limb migration >9 mm, one case had 10.6
mm and the second case had 21.3 mm of cranial movement.
Fig 7. Kaplan-Meier survival analysis illustrating freedom from
proximal stent graft migration. CI, Conﬁdence interval; CT,
computed tomography; SE, standard error.
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64%-94%), respectively. The magnitude and timings of
proximal migration are illustrated in Figs 6 and 7.
Using data from 55 patients, a total of 98 iliac limbs
were assessed for the presence of distal migration. In 11
patients (12 common iliac arteries), a CLL was unable to
be constructed. This was either due to an occluded internaliliac artery (n ¼ 7) or image quality issues (n ¼ 5). Of the
98 iliac limbs assessed, 10 (nine patients) showed evidence
of migration. Median distal migration was 5.0 (range,
4.3 to 21.3) mm (Table IV; Fig 6) with no clinical
sequelae or reinterventions. Based on an iliac limb follow-
up of 124.1 person-years, there was a distal migration
rate of one migration per 14 person-years of follow-up.
The probabilities of a patient being free from distal migra-
tion at 12 and 36 months were 97% (95% CI, 94%-100%)
and 92% (95% CI, 87%-99%), respectively (Fig 8). Analysis
on an individual iliac limb basis (ipsilateral/contralateral)
estimated that the probabilities of a patient being free
from migration at 12 and 36 months were 90.8% (95%
CI, 81.1%-100%%)/96.0% (95% CI, 90.7%-100%) and
80.0% (95% CI, 64.5%-99.3%)/90.7% (95% CI, 80.0%-
100%), respectively (Fig 9). Bilateral iliac limb migration
was seen in one patient, and combined proximal and at
least one iliac limb migration was seen in three patients.
Freedom from any (proximal/distal) migration at 12 and
36 months were 81% (95% CI, 71%-93%) and 64% (95%
CI, 49%-84%), respectively (Fig 10).
For those with CT evidence of proximal migration, two
patients had migration identiﬁed on the last follow-up CT
scan. For the remaining eight patients, there were only
minor amounts of further migration (mean, þ0.5 6 0.8
mm) during the remaining follow-up (mean, 36 6
15 months). Distally, three out of 10 limbs were identiﬁed
as migrated at last follow-up. For the remaining seven,
there was also only a small amount of further migration
(mean, 1.6 6 1.4 mm) over a mean 27 6 1 months.
DISCUSSION
Positional stability of a fenestrated stent graft is es-
sential to ensure long-term procedural success. With the
possibility of target vessel compromise and aneurysm reper-
fusion, migration of a fenestrated stent graft has raised
signiﬁcant concerns within the vascular community. Over
recent years there has been an increase in short- and
midterm outcome data for FEVAR.5-9 There is still,
however, little detailed information regarding migration
of fenestrated stent grafts.
Based on Kaplan-Meier analysis, 14% of our patients
had an estimated probability of proximal migration at 12
months; by 36 months, this had increased to 22%. Iliac
limb migrations were less frequent with 12- and 36-
month probabilities of 3% and 8%, respectively. Compar-
ison with the literature is problematic, as most reports
provide only limited references to device migration.5-10
Migration rates of 1%-7%5,7 have been reported and are
based on cases with clinical sequelae or requiring reinter-
vention. Troisi et al10 reported a higher incidence (24%),
all requiring reintervention. Their incidence was based
on a mix of branched, fenestrated, and combined
branched/fenestrated devices with migration only high-
lighted in cases with a type I endoleak. Eight cases of in-
stent stenosis or occlusion were also reported. It was not
clear if any of these resulted from device migration. If
we assume a similar classiﬁcation, then our migration
Table IV. Outcomes of patients with CT evidence of migration of iliac limb migration.
Case Limb
Time to
migration,
months
Migration
distance,
mm
Pre-op
AAA
diameter,
mm
Latest
AAA
diameter,
mm
Changes
in AAA
diameter,
mm Endoleak
Iliac
reintervention Outcome
1 (8) Ipsi 37.1 21.3 78 70 8 No No Alive at LFU (7 years) e see
proximal patient 8. No IRSI.
2 Contra 5.3 10.6 70 61 9 No No Alive at LFU (4 years), no compli-
cations/reinterventions.
3 (5) Ipsi 48.4 7.7 63 35 28 No No Died e NARC (8 years) e see
proximal patient 5. No IRSI.
4 Contra 5.4 7.5 58 53 5 Type II No Alive at LFU (3 years), no compli-
cations/reinterventions.
5 Contra 23.9 5.0 57 60 þ3 No No 4-year follow-up, died e NARC.
No complications/reinterven-
tions.
6 Ipsi 12.2 4.9 74 68 6 No No Alive at LFU (3 years), no compli-
cations/reinterventions.
7 (8) Contra 62.8 4.6 78 70 8 No No Alive at LFU (7 years) e see
proximal patient 8. No IRSI.
8 (4) Ipsi 89.5 4.4 69 87 þ18 No No Alive at LFU (9 years) e see
proximal patient 4. No IRSI.
9 Contra 38.0 4.4 85 86 þ1 Type II No Alive at LFU (4 years), no compli-
cations/reinterventions.
10 Contra 23.3 4.3 67 57 10 Type II No 2-year follow-up, died e NARC.
No complications/reinterven-
tions.
AAA, Abdominal aortic aneurysm; Contra, contralateral; CT, computed tomography; Ipsi, ipsilateral; IRSI, iliac-related secondary intervention; LFU, last
follow-up; LRA, left renal artery; NARC, nonaneurysm-related cause; SMA, superior mesenteric artery.
Changes in AAA diameter: negative values denote a reduction in AAA diameter whereas positive values highlight an increase. Numbers enclosed by the
parentheses in the ﬁrst column correspond to any related proximal migration cases in Table III.
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had stenosis (two SMAs, one RA). The two cases of RAs
occlusion were, however, deemed not to result from
migration. Patient 6 had patent RAs on both preoperative
and ﬁrst postoperative CT angiograms. A left RA occlusion
was reported at 2 years; it was a further 6 months before
device migration met our deﬁnition. Analysis of follow-
up imaging demonstrated no evidence of stent crushing
or fracture. Following occlusion, the patient’s serum creat-
inine levels rose from 94 to 134 mmol/L, without any
need for dialysis. Because of comorbidities, the patient
withdrew from follow-up at 5 years and has since died
from a nonrelated cause. Patient 7 also had a left RA occlu-
sion detected at 2 years, migration was detected a further
12 months after the vessel occlusion. During follow-up,
CT and ultrasound demonstrated a continual reduction
in left RA blood ﬂow and associated renal atrophy. A
minor RA stenosis with vessel calciﬁcation was seen on
the preoperative CT scan. The occlusion was, therefore,
believed to be a continuation of the patient’s renovascular
disease. Serum creatinine levels are stable (100 mmol/L),
and the patient was alive at last follow-up. Stent graft
migration with shuttering of the fabric over the vessel
ostium is a valid cause of target vessel loss. Other factors
include the misalignment of a fenestration during deploy-
ment, preoperative vessel quality, progression of athero-
sclerosis, distal embolization, and intimal hyperplasia.
Perhaps more importantly, in our series, there have beenno cases of proximal type I endoleak, rupture, or conver-
sion to open repair.
From our series, proximal migration occurred at
a mean rate of 8% per year, peaking by the end of the ﬁrst
year at 14%. This early peak may be the result of barb
engagement as an initial phase of stent graft movement
has been associated with barb engagement.3 Zhou et al3 re-
ported that a signiﬁcantly smaller force was needed to
engage the barbs into the aortic wall and following this
there is a period of high resistance to movement. This in vi-
tro work is important in that they compared a standard
infrarenal device with a single stented fenestrated device.
The addition of a stented fenestration increased the force
needed for initial displacement from 4.3 to 11.5 N (10%
oversizing). A further, ﬁnal phase of displacement required
an extra 6.4 and 16.8 N, for standard and fenestrated
devices respectively. From Zhou’s work, it is clear that
fenestrated stent grafts offer higher ﬁxation. The effect of
oversizing on device ﬁxation was also investigated. For
standard devices, increasing the oversizing from 5% to
10% and 5% to 20% required an extra 0.9 (27%) and 4.3
N (127%) of force for initial displacement. For a fenestrated
device, the extra force needed was less, 1 (9%) and 1.6 N
(16%). Final displacement of a fenestrated device required
an increase of 5.7 and 10.5 N, for 10% and 20% respective
oversizing compared with 2.7 and 8.7 N for a standard
device. Zhou’s work concluded that the protective beneﬁts
of oversizing a fenestrated device (>10%) are reduced in
Fig 8. Freedom from iliac limb migration. CI, Conﬁdence
interval; CT, computed tomography; SE, standard error.
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the additional ﬁxation provided by a single stented fenes-
tration and did not investigate whether there are additional
beneﬁts from using multiple stented fenestrations. In our
series, all 10 cases of proximal migration had stent graft
conﬁgurations, which included at least one stented renal
fenestration (Table III). A combination of barbs, fabric
extension into the suprarenal aorta, bare proximal stent
struts, and a separate proximal component are all likely to
contribute to the low incidence of proximal migration.
Other factors that may predict migration are impor-
tant. For standard devices these are well documented
and include AAA neck enlargement,17 angulation,18 the
use of proximal barbs,19 stent graft oversizing,3 and the
length of common iliac artery utilization.20 For fenestrated
stent grafts, the quantiﬁcation of oversizing may be difﬁ-
cult. The sealing stent is likely to oppose the aortic wall
over a range of aortic diameters. What may be a 20% over-
sizing at the SMA may reduce to 15% at the level of the
renal arteries or vice versa. In our series, device oversizing
was always in line with the manufacturer’s instructions for
use. Follow-up complications have also been linked, Li and
Kleinstreuer21 reported that the presence of endoleaks may
mitigate the risk of stent graft migration. More general
variables such as hypertension22 have also been reported
but as with oversizing may be harder to deﬁne. Categoriz-
ing a patient as hypertensive is difﬁcult since numerous
deﬁnitions exist,23 and measurements can vary dependingon the circumstances in which they are acquired.24 To
provide the best opportunity to identify predictive factors,
an appropriately designed study is needed. This must
include a carefully considered set of deﬁnitions, appro-
priate measurement techniques, and suitable numbers of
migration and nonmigration cases.
Distal migrations peaked between years 3 and 4 with
an annual migration rate of 8%. With a lack of published
data on the timings of distal migration, it is difﬁcult to
compare data between studies. In our series, migrations
were almost equally distributed between ipsilateral (n ¼
4) and contralateral (n ¼ 6) limbs. There were no cases
of distal type I endoleaks irrespective of the presence of
migration.
The separate proximal component of the Zenith fenes-
trated stent graft should help reduce the effects of the
caudally directed forces experienced at the aortic bifurca-
tion. This should help reduce the likelihood of migration
to the proximal component. Agreeing with this, Ziegler
et al6 stated that the lower rate of fenestrated stent graft
migration with the Zenith device is a result of a separate
proximal and bifurcation components.26 Although helpful
in opposing proximal migration this design brings the
added risk of component separation between the proximal
fenestrated and distal bifurcated pieces. With the additional
ﬁxation from target vessel stents, it is likely that we would
see a greater incidence of component separation than prox-
imal stent graft migration. Main body component distrac-
tion did occur in several of our patients. All were
successfully managed with either the implantation of
a bridging stent or using follow-up imaging. Conservative
management was used if the movement had ceased and
there was still good overlap between components.
Small movements have been associated with crushing
of a target vessel stent and vessel occlusion.5,8 In a series
reported by Verhoeven et al, migrations of <5 mm were
suspected in three cases; two of these resulted in a RA
occlusion.8 There is clearly a need to identify more subtle
levels of migration. The Cleveland group has already adop-
ted this principle. In their series, migration was deﬁned as
movement greater or equal to twice the CT slice thickness
or causing a clinical event. With the majority of centers
having access to thin-slice MDCT, it is perhaps time to
re-deﬁne stent graft migration.
In reporting this study, we accept that there are limita-
tions. Thirty-four percent of our patients were excluded;
this was primarily due to a lack of available follow-up CT
scans. Ten percent of patients had follow-up at another
institution, and whereas it may have been possible to locate
their CT data, it is likely that this may have been acquired
to a different protocol. To facilitate the detection of subtle
stent graft migration, all patients were followed up to
the same CT protocol using the same CT equipment.
O’Neill and colleagues25 highlighted potential problems
comparing studies that have been acquired to different
CT protocols. Differences in stent graft position during
the respiratory and cardiac cycles may also induce some
measurement errors. Vos et al highlighted that there can
Fig 9. Freedom from iliac limb migration (ipsilateral vs contralateral limbs). Upon visual inspection, there were no
apparent differences between limb types. CI, Conﬁdence interval; SE, standard error.
Fig 10. Freedom from any device migration. CI, Conﬁdence
interval; CT, computed tomography; SE, standard error.
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when imaged using cine magnetic resonance imaging.26
The movement of a deployed fenestrated stent graft in rela-
tion to the aortic wall is currently undeﬁned. However,
temporal changes in stent graft position resulting from
differences in the respiratory and cardiac cycle could
generate cases of pseudo-migration. We would argue thatby using a migration deﬁnition of movement $4 mm,
this is likely to reduce the likelihood of any temporal errors.
Rotational movement of a fenestrated stent graft is also
possible. Vessel occlusion and type III endoleaks have
been attributed to lateral rotation of a fenestrated stent
graft during follow-up.6 Rotation of the proximal compo-
nent is thought more likely to result from inadequate plan-
ning or rotational misalignment during deployment. In our
study we did not assess rotational migration but we would
recommend that clinicians actively scrutinize follow-up
imaging for rotational shuttering.
Our diagnosis of migration was based on the quantiﬁ-
cation of stent graft positional changes and the visual veri-
ﬁcation of any movements by two observers. Visual
veriﬁcation included the cross-referencing of stent graft
position against side-branches and aortic calciﬁcation.
Other indices were also considered, including changes to
the angulation of the target vessel stents. It was clear that
in all our cases of proximal migration, the device was
moving toward the renal arteries. Whether aortic elonga-
tion could mimic or mask cases of migration must also be
considered. Few reports have discussed the issue of aortic
elongation.25,27 Litwinski et al27 failed, in our opinion, to
demonstrate that for some patients the aorta lengthened
during follow-up. Their assumption was that if the length
of aortic neck increased, and there was no change to the
proximal ﬁxation length (top of the stent graft to the start
of the aneurysm) then this was indicative of aortic elonga-
tion. No evidence was provided that the distance between
the caudal renal artery and the aortic bifurcation increased.
It is possible, depending on measurement techniques and
deﬁnitions that the aortic neck length could increase in
a regressing aneurysm. The stent graft could still migrate
but because of the regression the proximal ﬁxation length
would remain relatively static. In our experience, we would
interpret any longitudinal movement of a stent graft in the
aorta as migration. Other authors have raised concerns
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tions, they too have supported the need for visually veri-
fying cases of suspected migration.
CONCLUSIONS
Suprarenal fabric extension and visceral artery stenting
are known to provide additional ﬁxation for fenestrated
aortic stent grafts. Despite this, minor proximal migration
still occurs in up to one quarter of FEVAR patients by 4
years. We believe this is mainly due to the engagement of
the barbs of the anchoring stent. Distal limb migrations
are fewer, and overall there is a low incidence of migration
related sequelae.
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